# Virios Therapeutics Inc. (VIRI)

Source: https://www.quantisnow.com/company/VIRI
Generated: 2026-11-17T13:53:24.507Z

- Ticker: VIRI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2020
- Website: virios.com

## About

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.

## Latest VIRI news and filings

- 2024-10-15 20:19 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Virios Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-virios-therapeutics-inc-5725789)
- 2024-10-07 12:06 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Virios Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-virios-therapeutics-inc-5717926)
- 2024-10-07 12:02 UTC [SEC Form 8-K] [Virios Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/virios-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5717920)
- 2024-10-07 11:05 UTC [Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: "DWTX")](https://www.quantisnow.com/insight/virios-therapeutics-inc-and-wex-pharmaceuticals-inc-announce-business-combination-5717767)
- 2024-08-09 14:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Virios Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-virios-therapeutics-inc-5652346)
- 2024-08-08 13:30 UTC [SEC Form 8-K] [Virios Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/virios-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5649713)
- 2024-08-08 13:15 UTC [Public Offering] [Virios Therapeutics Announces Second Quarter 2024 Financial Results](https://www.quantisnow.com/insight/virios-therapeutics-announces-second-quarter-2024-financial-results-5649681)
- 2024-08-01 13:41 UTC [Earnings Date] [Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024](https://www.quantisnow.com/insight/virios-therapeutics-to-report-second-quarter-2024-financial-results-on-5637448)
- 2024-07-23 16:17 UTC [Market Chatter] [Virios Therapeutics shares are trading higher after the company announced the Bateman Horne Center completed enrollment in its investigator-initiated, proof of concept LC study.](https://www.quantisnow.com/insight/virios-therapeutics-shares-are-trading-higher-after-the-company-announced-5622250)
- 2024-07-23 13:15 UTC [Market Chatter] [Virios Therapeutics Announces Completion Of Enrollment In Proof Of Concept Long-COVID Study; Top Line Results Expected In October 2024; Study Highlights Potential For Antiviral Therapy To Treat Long-COVID Symptoms](https://www.quantisnow.com/insight/virios-therapeutics-announces-completion-of-enrollment-in-proof-of-concept-5621875)
- 2024-07-23 13:15 UTC [Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center](https://www.quantisnow.com/insight/virios-therapeutics-announces-completion-of-enrollment-in-imc-2-phase-2-5621866)
- 2024-07-22 17:28 UTC [Market Insight] [Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-crowdstrike-shares-are-trading-lower-by-around-13-here-5619804)
- 2024-07-22 09:24 UTC [Market Insight] [Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-tellurian-shares-are-trading-higher-by-around-65-here-5618435)
- 2024-07-18 10:00 UTC [Market Insight] [Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-chuys-holdings-shares-are-trading-higher-by-47-here-5614226)
- 2024-06-20 13:15 UTC [SEC Form 8-K] [Virios Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/virios-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-5567625)
- 2024-06-20 12:22 UTC [Market Insight] [Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-vuzix-shares-are-trading-higher-by-around-15-here-5567316)
- 2024-06-20 11:47 UTC [Market Chatter] [Maxim Group Initiates Coverage On Virios Therapeutics with Buy Rating, Announces Price Target of $1](https://www.quantisnow.com/insight/maxim-group-initiates-coverage-on-virios-therapeutics-with-buy-rating-5567102)
- 2024-06-12 13:15 UTC [SEC Form 8-K] [Virios Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/virios-therapeutics-inc-filed-sec-form-8-k-notice-of-delisting-5553065)
- 2024-06-06 17:39 UTC [Market Insight] [Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-g-iii-apparel-shares-are-trading-lower-by-13-here-5542068)
- 2024-05-30 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-after-market-session-5526779)
- 2024-05-28 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5520307)
- 2024-05-22 17:30 UTC [Public Offering] [Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study](https://www.quantisnow.com/insight/virios-therapeutics-announces-closing-of-17-million-public-offering-of-5510009)
- 2024-05-20 20:22 UTC [Market Chatter] [Virios Therapeutics Inc. To Offer 8.5M Shares Of Common Stock At $0.20 Per Share](https://www.quantisnow.com/insight/virios-therapeutics-inc-to-offer-85m-shares-of-common-stock-5504312)
- 2024-05-20 20:05 UTC [SEC Form 424B4 filed by Virios Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-virios-therapeutics-inc-5503995)
- 2024-05-20 18:31 UTC [Market Insight] [Dow Falls Over 150 Points; Sohu Posts Q1 Loss](https://www.quantisnow.com/insight/dow-falls-over-150-points-sohu-posts-q1-loss-5503675)
- 2024-05-20 17:28 UTC [Market Insight] [Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-virios-therapeutics-shares-are-trading-lower-by-around-48-5503585)
- 2024-05-20 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-5503509)
- 2024-05-20 16:03 UTC [Market Insight] [Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results](https://www.quantisnow.com/insight/nasdaq-surges-100-points-wixcom-shares-jump-following-q1-results-5503455)
- 2024-05-20 13:57 UTC [Market Insight] [US Stocks Mixed; Li Auto Shares Plummet After Q1 Results](https://www.quantisnow.com/insight/us-stocks-mixed-li-auto-shares-plummet-after-q1-results-5503230)
- 2024-05-20 13:28 UTC [SEC Form 8-K] [Virios Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/virios-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5503177)
- 2024-05-20 12:09 UTC [Market Insight] [Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-wixcom-shares-are-trading-higher-by-7-here-are-5502834)
- 2024-05-20 12:06 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-5502820)
- 2024-05-20 11:36 UTC [Market Chatter] [Virios Therapeutics shares are trading lower after the company priced a $1.7 million pubic offering of 8.5 million shares of common stock at $0.20 per share.](https://www.quantisnow.com/insight/virios-therapeutics-shares-are-trading-lower-after-the-company-priced-5502673)
- 2024-05-20 04:43 UTC [Market Chatter] [Reported Earlier, Virios Therapeutics Prices $1.7M Public Offering Of 8.5M Common Stock To Commence Preparations For Planned IMC-2 Long-COVID Phase 2b Study At $0.20/Share](https://www.quantisnow.com/insight/reported-earlier-virios-therapeutics-prices-17m-public-offering-of-85m-5502243)
- 2024-05-20 00:53 UTC [Public Offering] [Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study](https://www.quantisnow.com/insight/virios-therapeutics-announces-pricing-of-17-million-public-offering-of-5502236)
- 2024-05-17 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-after-market-session-5500879)
- 2024-05-17 20:11 UTC [Market Chatter] [Virios Therapeutics shares are trading lower after the company announced a proposed public offering to commence preparatory activities for its planned IMC-2 Long-COVID Phase 2b study.](https://www.quantisnow.com/insight/virios-therapeutics-shares-are-trading-lower-after-the-company-announced-5500470)
- 2024-05-17 20:11 UTC [Market Chatter] [Virios Therapeutics Announces $2.1M Proposed Public Offering Of Common Stock](https://www.quantisnow.com/insight/virios-therapeutics-announces-21m-proposed-public-offering-of-common-stock-5500448)
- 2024-05-17 20:10 UTC [Public Offering] [Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study](https://www.quantisnow.com/insight/virios-therapeutics-announces-proposed-public-offering-of-common-stock-to-5500429)
- 2024-05-17 20:01 UTC [SEC Form 424B4 filed by Virios Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-virios-therapeutics-inc-5500169)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VIRI
- Earnings history: https://www.quantisnow.com/earnings/VIRI
- Dividend history: https://www.quantisnow.com/dividends/VIRI
- Insider transactions: https://www.quantisnow.com/insiders/VIRI
- Options chain: https://www.quantisnow.com/options/VIRI
- SEC 8-K filings only: https://www.quantisnow.com/company/VIRI/8-k
- RSS and alerts for VIRI: https://www.quantisnow.com/docs/rss-feeds.md
